Home > News & Commentary > Commentary > Health Law and COVID-19

Health Law and COVID-19

On September 16, Harvard Law School’s Colloquium series titled, COVID-19 and the Law: Law and Policy to Address Basic Needs and Marginalized Populations, hosted a discussion on Health Law and COVID-19, featuring Robert Greenwald, Clinical Professor of Law and Faculty Director of the Center for Health Law and Policy Innovation; Glenn Cohen, Professor of Law and Faculty Director of the Petrie-Flom Center for HealthLaw Policy, Biotechnology & Bioethics; and Peter Barton Hutt, former FDA Chief Counsel and leading Food and Drug Law scholar. The discussion covered a range of legal questions related to the U.S. health and public health response to COVID-19, including: testing, treatment, and vaccine development and approval; ethical and liability questions related to allocation of medical equipment; questions about disability and age discrimination in treatment and care; and questions of health care access and health equity, among others.

Visit the Colloquium’s website for more information, and watch the recording here:

Pin It on Pinterest